We are live on ! Find out more
CANC icon

Tema Oncology ETF
CANC

3 hedge funds and large institutions have $250K invested in Tema Oncology ETF in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1.43% more ownership

Funds ownership: 0% → 1.43% (+1.4%)

Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$211K
2
HI
Harbour Investments
Wisconsin
+$7.43K
3
Osaic Holdings
Osaic Holdings
Arizona
+$3.53K

Top Sellers

No sellers this quarter

CANC Hedge Fund Activity: Q4 2023 in Review

3 of the 6,872 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q4 2023, worth a combined $250K.

Buyers outnumbered sellers: 3 funds opened new CANC positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $211K.

  • 3 institutional investors held Tema Oncology ETF (CANC) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $250K of Tema Oncology ETF stock for Q4 2023.
  • 3 funds opened new Tema Oncology ETF positions in Q4 2023 and 0 closed out, a net change of +3 holders.
  • The largest Tema Oncology ETF buyer in Q4 2023 was Jane Street, an estimated $211K added.

Based on aggregated 13F filings for Q4 2023.